Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients with Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial)

Despite the well-established benefits of mineralocorticoid receptor agonists (MRAs) in heart failure with reduced ejection fraction, safety concerns remain in patients with concomitant diabetes mellitus (DM) because of common renal and electrolyte abnormalities in this population. We analyzed all-ca...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vaduganathan, Muthiah, Cas, Alessandra Dei, Mentz, Robert J., Greene, Stephen J., Khan, Sadiya, Subacius, Haris P., Chioncel, Ovidiu, Maggioni, Aldo P., Konstam, Marvin A., Senni, Michele, Fonarow, Gregg C., Butler, Javed, Gheorghiade, Mihai
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4160659/
https://ncbi.nlm.nih.gov/pubmed/25060414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2014.05.064
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados